Vaccine dilemma for children at risk: Recently approved malaria vaccine versus ongoing COVID-19 vaccination campaign

Recently, the World Health Organization (WHO) approved RTS, S/AS01 (RTS, S) as the world's first malaria vaccine for partial malaria protection in young children at risk. While this immunization drive begins during the unprecedented pandemic of the SARS-CoV-2 Virus, the WHO has also approved 7...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Pritik A., Hasan, Mohammad Mehedi, Sahito, Abdul Moiz, Patel, Suyog Y., Ramproshad, Sarker, Mondal, Banani, Essar, Mohammad Yasir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212924/
https://www.ncbi.nlm.nih.gov/pubmed/35757307
http://dx.doi.org/10.1016/j.amsu.2022.104011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212924/
https://www.ncbi.nlm.nih.gov/pubmed/35757307
http://dx.doi.org/10.1016/j.amsu.2022.104011

Ejemplares similares